informed judgements on which one will best meet your needs. We collect data directly from providers through detailed questionnaires, and conduct first-hand testing and observation through provider ...
Regulatory ApprovalFormycon and Fresenius Kabi announce MHRA approval for FYB202/Otulfi® (ustekinumab), a biosimilar to Stelara® 15.01.2025 / 06:30 CET/CESTThe issuer is solely responsible for the ...